Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-15 1:19 pm Purchase | 2022-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT | Western Standard LLC | 424,080 6.600% | 41,507 (+10.85%) | Filing History |
| 2022-11-28 4:07 pm Purchase | 2022-11-16 | 13G | Opiant Pharmaceuticals, Inc. OPNT | Western Standard LLC | 382,573 6.000% | 382,573 (New Position) | Filing History |
| 2022-06-17 4:53 pm Sale | 2022-01-26 | 13D | Opiant Pharmaceuticals, Inc. OPNT | CRYSTAL ROGER | 636,594 11.200% | -96,881 (-13.21%) | Filing History |
| 2022-06-17 4:52 pm Sale | 2021-08-23 | 13D | Opiant Pharmaceuticals, Inc. OPNT | Sinclair Michael | 515,170 9.300% | -230,000 (-30.87%) | Filing History |
| 2022-02-11 09:32 am Sale | 2021-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT | RENAISSANCE TECHNOLOGIES LLC | 183,815 3.890% | -53,000 (-22.38%) | Filing History |
| 2022-01-27 10:12 am Sale | 2021-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT | WELLS FARGO & COMPANY WFC | 224,297 4.750% | -27,908 (-11.07%) | Filing History |
| 2021-02-16 2:28 pm Sale | 2020-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT | Radoff Bradley Louis | 18,000 1.000% | -259,500 (-93.51%) | Filing History |
| 2021-02-12 5:08 pm Sale | 2020-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT | Stonepine Capital Management LLC | 0 0.000% | -334,272 (Position Closed) | Filing History |
| 2021-02-11 4:37 pm Purchase | 2020-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT | WELLS FARGO & COMPANY WFC | 252,205 5.920% | 252,205 (New Position) | Filing History |
| 2021-02-11 2:04 pm Sale | 2020-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT | Altium Capital Management LLC | 0 0.000% | -349,846 (Position Closed) | Filing History |
| 2021-02-10 4:09 pm Purchase | 2020-07-17 | 13G | Opiant Pharmaceuticals, Inc. OPNT | RENAISSANCE TECHNOLOGIES LLC | 236,815 5.560% | 236,815 (New Position) | Filing History |